Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04585074 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04585074 · ClinicalTrials.gov record · last posted 2025-05-15

Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery

Study acronym: MARRES
StatusActive, Not Recruiting
PhaseNot specified
Started2020-04-08
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 15, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Robotic mastectomy and immediate reconstruction have been introduced in 2015. However, since robotic mastectomy is the latest surgical technique, there is a lack of studies prospectively comparing conventional mastectomy and immediate reconstruction with robotic mastectomy. For this reason, this study is designed to establish a single institution cohort study that prospectively collects patients undergoing mastectomy and reconstruction. This study was initially designed as a single institution study, however, currently, the study was extended to the multicenter study including 18 institutions over the country. Using the established prospective cohort data, a comparative study of robotic mastectomy with conventional mastectomy and reconstruction, and cost-effectiveness and satisfaction of robotic endoscopic surgery, and cost-effectiveness and satisfaction of reconstructive surgery are to be analyzed.

Amendment record 6 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 6 times since 2020-10-10; most recent amendment 2025-05-12. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-05-12
Status change Recruiting→Active, Not Recruitingv6
Trial Details
NCT Number NCT04585074
Lead Sponsor Severance Hospital
Conditions Breast Neoplasms, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Benign Breast Disease, Germline Mutation Abnormality
Enrollment 2,000 participants
Start Date 2020-04-08
Primary Completion 2025-06-30 (estimated)
Study Completion 2030-04-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-15